HIIFS
FOMX

Harel Insurance Investments & Financial Services’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,571
Closed -$61K – 548
2018
Q3 		$61K Buy
+10,571
New +$60.5K ﹤0.01% 321
2018
Q2 		– Sell
-2,707
Closed -$14K – 506
2018
Q1 		$14K Buy
+2,707
New +$16.3K ﹤0.01% 408

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Harel Insurance Investments & Financial Services's FOMX Position: Q4 2018 in Review

Harel Insurance Investments & Financial Services sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2018, closing a stake of 10,571 shares — an estimated $61K sold.

Harel Insurance Investments & Financial Services first reported a position in FOMX in Q1 2018 and held it in 2 quarters. The position peaked at $61K in Q3 2018. 66 funds tracked by Wall St. Rank hold FOMX as of Q4 2018.

  • Harel Insurance Investments & Financial Services reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 10,571 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2018, an estimated $61K.
  • Harel Insurance Investments & Financial Services first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2018 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $61K in Q3 2018.
  • 66 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2018.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2018, filed 29 Jan 2019.